Eleusis
Eleusis Ltd. operates a single Caribbean retreat facility in Bequia (Saint Vincent and the Grenadines) delivering medically supervised extended-DMT (DMTx) therapy via four-day packages starting at $9,500, targeting affluent US and international wellness tourists seeking legal, research-backed psychedelic therapy.
- Company typePrivate
- Founded2026
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
Eleusis firmographics
Firmographics- Name
- Eleusis
- Legal name
- Eleusis Ltd.
- Website
- https://eleusisltd.com
- Company type
- Private
- Founded year
- 2026
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Eleusis Ltd. operates a single Caribbean retreat facility in Bequia (Saint Vincent and the Grenadines) delivering medically supervised extended-DMT (DMTx) therapy via four-day packages starting at $9,500, targeting affluent US and international wellness tourists seeking legal, research-backed psychedelic therapy.
- Ownership category
- akta.pro rank
Eleusis industry classification
Industry- Product category
- Psychedelic Therapy Services
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP) (HLAFACAJ)
Keywords
Where Eleusis is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Eleusis business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Therapeutic Retreat Packages: Four-day DMTx therapeutic packages offered at the Bequia retreat facility, providing medical supervision, accommodation, and guided sessions. This represents the primary revenue stream for the company.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Standard four-day DMTx retreat package |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Eleusis product offering
Product offeringCore offering
Eleusis operates a psychedelic retreat and research facility on the island of Bequia (Saint Vincent and the Grenadines), where it sells four-day, medically supervised DMTx (extended DMT) therapy packages starting at $9,500 per person. The offering is built around a target-controlled IV infusion protocol that prolongs the DMT experience, developed from Imperial College London's 2022 clinical research, and is positioned as a regulated, science-backed alternative to ayahuasca ceremonies.
Differentiator
Problem solved
Functional benefit
Products and services
- Eleusis Retreat and Research Facility — Four-Day DMTx Therapeutic Package A four-day, all-inclusive, medically supervised DMTx (extended DMT) therapy package delivered at the Eleusis retreat and research facility on Bequia, Saint Vincent and the Grenadines. Built on a target-controlled intravenous infusion protocol pioneered in Imperial College London's 2022 clinical research (11 volunteers), it provides accommodation, medical supervision, and guided therapeutic sessions as a science-backed, regulated alternative to ayahuasca ceremonies for individuals seeking legal psychedelic-assisted therapy.
Quantifiable outcome
- First clinical study with extended DMT (DMTx) using target-controlled intravenous infusion was conducted with 11 volunteers at Imperial College London in 2022
Companies that use Eleusis
Customer profileSegments1 record
Ideal customer profiles1 record
Eleusis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Eleusis partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NoonauticscoreNonprofit organization providing oversight for Eleusis operations. Noonautics serves as the governing nonprofit entity that ensures ethical standards and research integrity for the psychedelic therapy programs. The partnership legitimizes Eleusis's research-focused approach to DMT therapy.
Scale indicators2 records
Eleusis competitors and assessment
Company assessmentDirect peers
- Synthesis Institute: Operates legal psilocybin retreats in the Netherlands and Jamaica with a science-forward, medically supervised model. Directly comparable to Eleusis as a premium, research-credentialed psychedelic retreat operator serving international wellness travelers.
- Beckley Retreats: Runs psilocybin-assisted retreats in Jamaica and the Netherlands grounded in Beckley Foundation research. Closely comparable to Eleusis in combining published academic research, premium pricing, and a legal-jurisdiction retreat model.
- Rythmia: Luxury ayahuasca retreat in Costa Rica offering all-inclusive plant medicine programs. Directly comparable to Eleusis in pricing structure, medical oversight claims, and target demographic of affluent international wellness travelers.
- Soltara Healing Center: Plant medicine retreat center in Costa Rica offering ayahuasca ceremonies with medical staff. Comparable as a legally operating, medically supervised psychedelic retreat serving international clientele at premium price points.
Broad incumbents
- Atai Life Sciences: Public psychedelic biopharma (NASDAQ: ATAI) developing multiple psychedelic therapeutics. Comparable through shared founder lineage with Eleusis and overlapping interest in DMT-class molecules, though Atai operates in clinical drug development rather than retreats.
- Field Trip Health: Operated ketamine-assisted therapy clinics across North America before restructuring. Comparable as a clinically supervised psychedelic therapy service business targeting mental health indications.
- MindMed: Public psychedelic medicine company developing LSD and MDMA-based therapies. Comparable in pursuing clinically validated psychedelic protocols for mental health, though focused on pharmaceutical development rather than retreat delivery.
- Compass Pathways: Public company developing COMP360 psilocybin therapy for treatment-resistant depression. Comparable as a research-driven psychedelic therapeutics company pursuing regulated clinical pathways.
Emerging players
- Silo Wellness: Operates ketamine retreats and psychedelic wellness clinics in Jamaica and the US. Comparable as an emerging psychedelic retreat operator exploring both legal-jurisdiction and domestic supervised administration models.
- Mycelia Retreats: Boutique psilocybin retreat operating in the Netherlands. Comparable as a smaller, science-adjacent European psychedelic retreat operator in the same premium international-traveler segment.
Market position
Customer concentration
Eleusis social profiles
Digital presenceEleusis financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eleusis leadership team
Management profileNumber of profiles
Profiles3 records
Eleusis funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eleusis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eleusis
What does Eleusis do?
Eleusis operates a psychedelic retreat and research facility on the island of Bequia (Saint Vincent and the Grenadines), where it sells four-day, medically supervised DMTx (extended DMT) therapy packages starting at $9,500 per person. The offering is built around a target-controlled IV infusion protocol that prolongs the DMT experience, developed from Imperial College London's 2022 clinical research, and is positioned as a regulated, science-backed alternative to ayahuasca ceremonies.
Is Eleusis a public or private company?
Eleusis is a private company. It is classified as venture growth investor backed and is currently operating.
When was Eleusis founded?
Eleusis was founded in 2026. It employs 11 to 50 people.
Where is Eleusis based?
Eleusis is headquartered in London, United Kingdom, in the Europe region.
How does Eleusis make money?
One revenue line is on record: therapeutic Retreat Packages.
Who are Eleusis's main competitors?
Direct peers on record are Synthesis Institute, Beckley Retreats, Rythmia and Soltara Healing Center. Broad incumbents are Atai Life Sciences, Field Trip Health, MindMed and Compass Pathways. Emerging players are Silo Wellness and Mycelia Retreats.
Does Eleusis have an API?
No public API is recorded for Eleusis.
What industry is Eleusis in?
Eleusis's product category is Psychedelic Therapy Services. Its primary akta.pro industry code is HLAFACAJ, Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP). Its NAICS code is 621420 and its SIC code is 8093.